LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
3.56
EUR
-0.02
EUR
-0.62
%
16.10.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 3.95 USD | -0.08 USD | -1.96 % |
|---|
| Vortag | 4.03 USD | Datum | 13.10.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 179.53% | |
| 21Shares Stacks ETP | CH1258969042 | 149.33% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 144.23% | |
| 21shares Ethena ETP | CH1506167035 | 132.32% | |
| 21Shares Arbitrum ETP | CH1304867463 | 95.03% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 258.96% | |
| 21Shares Raydium ETP | CH1480821391 | 187.57% | |
| 21Shares Injective Staking ETP | CH1360612134 | 155.31% | |
| 21Shares Uniswap ETP | CH1135202096 | 122.21% | |
| 21shares Ethena ETP | CH1506167035 | 99.66% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 107.55% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 101.99% | |
| 21Shares Uniswap ETP | CH1135202096 | 6.66% | |
| 21Shares Raydium ETP | CH1480821391 | -4.26% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | -5.14% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 133.58% | |
| 21Shares Stellar ETP | CH1109575535 | 88.38% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 53.07% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 52.09% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 23.95% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 1’214’661.71 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 15.10.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 57.70 | |
| Performance 2 Jahre | 90.20 | |
| Performance 3 Jahre | 90.06 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |